Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Genevant Sciences - Career Page
Genevant Sciences Announces Global Collaboration and License Agreement ...
Editas Medicine and Genevant Sciences to Collaborate to Develop Novel ...
Genevant Sciences and Arbutus Biopharma Initiate
Genevant Sciences | LinkedIn
Our technology - Genevant Sciences Corporation
Home - Genevant Sciences Corporation
Genevant Sciences | The Org
Join us - Genevant Sciences Corporation
About us - Genevant Sciences
Our team - Genevant Sciences
Partnering - Genevant Sciences
Join us - Genevant Sciences
Publications - Genevant Sciences Corporation
Our team - Genevant Sciences Corporation
Rewards - Genevant Sciences
Contact us - Genevant Sciences
Arbutus and Roivant Launch Genevant Sciences with $37.5M in Seed ...
Genevant Sciences CEO joins board at Danish oncology firm
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion G
Editas Medicine partners with Genevant Sciences to develop gene editing ...
Genevant Sciences GmbH – Swiss Biotech
Genevant Sciences, Corp., Author at Life Sciences British Columbia
Genevant Sciences GmbH | Reuters
Genevant combina su tecnología con Tome Biosciences para desarrollar ...
Genevant LIPID CL1|Ionizable Lipid for LNP
Arbutus and Roivant Sciences Launch Genevant Sciences with Industry ...
Genevant and Takeda to develop gene therapies for liver diseases
Genevant and Tome Collaborate to Develop Gene Editing Therapy for Rare ...
Genevant and Arbutus agree $2.25 billion global settlement with Moderna ...
Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 ...
BioNTech and Genevant Sciences Sign Strategic mRNA-Focused Partnership ...
Epitopea and Genevant Sciences Announce Collaboration Agreement - Epitopea
Epitopea’s deal with Genevant Sciences is worth $123.5m per product
Genevant CL1|Cas# 1450888-71-7
Repair Biotechnologies to Leverage Genevant Sciences’ LNP Technology ...
2seventy brings in Genevant delivery tech for Novo Nordisk in vivo gene ...
Mark Wood - Principal Scientist, Chemistry. at Genevant Sciences | The Org
LDS - Learn. Develop. Succeed. on LinkedIn: Thank you, Genevant ...
LDS and Genevant Partnership | News & Articles
Genevant CL1 monohydrochloride - 瑞禧生物
Genevant CL1 (lipid 10) 新型阳离子脂质 -艾伟拓(上海)医药科技有限公司
#tidesusa | Genevant Sciences
Genevant CL1 monohydrochloride，可电离的阳离子脂质-UDP糖丨MOF丨金属有机框架丨聚集诱导发光丨荧光标记推荐 ...
Genevant tests UPC long-arm jurisdiction against Moderna with latest ...
Repair and Genevant team up for novel atherosclerosis treatment ...
Genevant CL1 | Lipid-10 | 可电离脂质 | LNP脂质纳米颗粒 | TargetMol
Arbutus, Genevant Mustn’t Dodge Vaccine Tech Suit, Acuitas Urges
Moderna Settles with Genevant and Arbutus, Ending LNP Patent Dispute
超8亿元！LNP龙头Genevant Sciences与Tome合作开发肝病基因编辑疗法医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Silicon Ether Ionizable Lipids Enable Potent mRNA Lipid Nanoparticles ...
March 8 2023
Slide 55
诺和诺德：2023年四次加码递送技术，与LNP先锋Genevant合作开发 A 型血友病基因编辑疗法_腾讯新闻
张锋教授的公司，豪掷2.38亿美元！与Genevant达成新型mRNA-LNP基因编辑疗法合作医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
BioNTech-Genevant “희귀질환 mRNA 신약 공동개발“ - 바이오스펙테이터
Our Companies | Roivant
WIB | Work in biotech
Tides 速递 | Genevant与诺和诺德合作开发 A 型血友病基因编辑疗法 - 知乎
Roivant
Slide 51
武田薬品、スイスGenevant社のLNPで肝疾患に遺伝子治療を開発へ：日経バイオテクONLINE
Top 23 Biotech Companies in Vancouver [2023]
Moderna Resolves Global Patent Litigation with Arbutus/Genevant
Top 13 Liver Disease treatment startups 2026
NanoMedicines Research Group
